Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Drops By 46.5%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 27,800 shares, a decrease of 46.5% from the November 30th total of 52,000 shares. Based on an average trading volume of 276,600 shares, the days-to-cover ratio is presently 0.1 days.

Biodexa Pharmaceuticals Stock Performance

BDRX stock traded down $0.41 during trading on Friday, reaching $4.29. The stock had a trading volume of 18,151 shares, compared to its average volume of 144,341. The firm’s 50 day moving average is $5.05. Biodexa Pharmaceuticals has a 52 week low of $3.50 and a 52 week high of $74.00.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.